McKesson’s Sarah Alwardt, Ph.D, recently wrote in OncLive about the importance of real-world evidence (RWE) in the field of cancer treatment research. Fewer than 5 percent of adults with cancer enroll in clinical trials, but sufficient enrollment is necessary in order to successfully complete randomized controlled...
McKesson Ventures Principal Carrie Hurwitz Williams has been honored as one of 10 Global Corporate Venturing Rising Stars. Williams joined McKesson Ventures in 2017, bringing with her more than 15 years of experience in health care from several vantage points within the industry. She was attracted...
Matternet, a company focused on providing drone delivery for medical applications, announced a strategic investment from McKesson Ventures. McKesson Ventures joins Matternet’s current investors, Boeing, Sony, and Mercedes-Benz, along with a growing list of strategic partners including UPS and Swiss Post. Matternet has created a new...
The finalists have been announced for this year’s Business Plan Competition and AARP Innovation Labs Pitch Competition. The business plan competition features companies pitching their ideas to a diverse panel of judges for feedback, funding, and a $10,000 prize. Judges for the business plan competition were...
McKesson Ventures Director Irem Mertol was featured as an investor to watch in the latest issue of Startup Health magazine. Mertol, whose work focuses on early to growth-stage investments across healthcare technology and services, has been with McKesson Ventures since 2017. Her most recent investment was...
Tom Rodgers, senior vice president and managing director of McKesson Ventures, has been named to the Global Corporate Venturing 2018 Powerlist. Under Tom Rodgers’ leadership, McKesson Ventures (which launched in 2014) has made several investments, including a $1.2 billion series B round for GRAIL Inc. in...
Senior vice president and managing director of McKesson Ventures Tom Rodgers reported that the firm broke precedent with its investment in GRAIL Inc. The investment was unusual for the company in two ways; it was one of the firm’s larger spends, and it was also toward...
Vator recently held the first of four events centered around the advances in healthcare. The first panel featured venture capitalists who are investing heavily in healthcare technologies, including McKesson Ventures’ Managing Director Dave Schulte. On the question of what the panelists see as driving the future...
Medical startups need to communicate their progress well, or they set themselves up for failure. Theranos Inc. is the most recent example of how negligence can carry big consequences. Venture capitalists and entrepreneurs attribute the company’s downfall to a failure to be transparent in dealings...
What’s the second richest company in California? If you can’t answer that question, you aren’t the only one. The answer? McKesson Corporation. According to Fortune, McKesson is “a massive corporation hiding in plain sight.” A distributor of pharmaceuticals and other medical supplies, McKesson is often overlooked...